The effects of CIK cells on the treatment of renal cell carcinoma

  • Kaijian Lei
  • Jing Wang
  • Yuming Jia
  • Yongxiang Xiong
  • Ziping Yuan
Article

Abstract

Objective

To observe the effects of cytokine-induced killer (CIK) cells on the treatment of renal cell carcinoma.

Methods

Twenty-eight postoperative cases with stage I or stage II renal cell carcinoma were admitted in our hospital from January 2002 to June 2006, all cases were pathologically confirmed, and were divided into group A (18 cases) and group B (10 cases). Group A was administrated 3–12 periods of CIK cells treatment combined with 5–7 cycles of IL-2 and INFα-2b, together with 4 cycles of chemotherapy (5-Fu + CF). Group B was given 4 cycles of chemotherapy (5-Fu + CF) and 5–7 cycles of IL-2 and INFα-2b.

Results

Three cases in group A had metastatic masses in two lungs within 1 year and died within 2 years postoperatively. The other 15 cases are still alive and in good health. Six cases in group B had metastatic masses in two lungs or/and in abdominal cavity within 1 year, and 4 of them died within 2 years. All the 6 cases died within 3 years. The other 4 cases are still alive and in good health.

Conclusion

CIK cells are safe and effective for the treatment of stage I or stage II renal cell carcinoma, which should be further widely used.

Key words

cytokine-induced killer (CIK) cells renal cell carcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chen FX, Liu JQ, Zhang NZ. Clinical observation of immunotherapy for malignant carcinoma by autonomous CIK cells. Chin J Cancer (Chinese), 2002, 21: 797–801.Google Scholar
  2. 2.
    Ren H, Xu HW, Song YH, et al. In vitro proliferation of CIK cells and their clinical antineoplastic activities. Chin J Immunol (Chinese), 1998, 14: 406–408.Google Scholar
  3. 3.
    Du QY, Liu MX, Wang FS, et al. Antitumor effects of CIK cells against hepatocellular carcinoma cells in vitro and in vivo. Chin Oncol (Chinese), 2001, 11: 325–327.Google Scholar
  4. 4.
    Sun S, Li XM, Wang JG, et al. Studies on anti-proliferation and inducing apoptosis effects of CIK cells against MGC-803 gastric cancer cell lines. Chin J Immunol (Chinese), 2004, 20: 831–833.Google Scholar
  5. 5.
    Shi YG, Yu JR, Cen XN, et al. Large capacity expanded cytoline-induced killer cells and its cytotoxic activity. J Biomed Eng, 2001, 18: 94–96.Google Scholar
  6. 6.
    Tong CR, Geng YB, Lu DP. A pilot report of the effect of auto-cytokine induced killers on the patients with acute leukemia. J Peking Univ (Health Sciences) (Chinese), 2000, 32: 473–477.Google Scholar
  7. 7.
    Lenhard RE, Osteen RT, Gansler T. Clinical Oncology. 1st ed. Atlanta: American Cancer Society, 2001. 415–419.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Kaijian Lei
    • 1
  • Jing Wang
    • 1
  • Yuming Jia
    • 1
  • Yongxiang Xiong
    • 1
  • Ziping Yuan
    • 1
  1. 1.Department of OncologyThe No. 2 People’s Hospital of YibinYibinChina

Personalised recommendations